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PURPOSE: Living donor nephrectomy is usually performed by a retroperitoneal flank incision. Due to the significant morbidity 
and long recovery time for a flank incision, anterior extra peritoneal sub-costal and transperitoneal video-laparoscopic methods have 
been described for donor nephrectomy. We prospectively compare the long-term results of donors as well as functional recipients 
submitted to these three approaches.
MATERIALS AND METHODS: A total of 107 live donor renal transplantations were prospectively evaluated from May 2001 
to January 2004. Donors were compared with regard to operative and warm ischemia time, postoperative pain, analgesic require-
ments, and complications. Recipients were compared with regard to graft function, acute cellular rejection, surgical complications, 
and graft and recipient survival.
RESULTS: The mean operative and warm ischemia times were longer in the video-laparoscopic group (p<0.001), whereas patients 
of the flank incision group presented more postoperative pain (p=0.035), required more analgesics (p<0.001), had longer hospital 
stays (p<0.001), and suffered more pain on the 90th day after surgery (p=0.006). In the sub-costal and flank incision groups, there 
was a larger number of paraesthesias and abdominal wall asymmetries (p<0.001). Recipient groups were demographically compa-
rable and presented similar acute tubular necrosis incidence and delayed graft function. The incidence of acute cellular rejection was 
higher in the video-laparoscopic and flank incision groups (p=0.013). There was no difference in serum creatinine levels, surgical 
complications, or recipient or graft survival between groups.
CONCLUSIONS: The video-laparoscopic and sub-costal approaches proved to be safe, and to provide donor advantages relative 
to the flank incision approach. Among recipients, the complication rate, graft survival, and recipient survival were similar in all 
groups.
KEYWORDS: Donor nephrectomy; Kidney transplantation; Laparoscopy; Surgical approaches; Outcomes.
INTRODUCTION
The aim of donor nephrectomy is to achieve an adequate 
graft with the lowest morbidity to the donor. During recent 
decades, the best approach has been a large flank incision 
with a rib resection. Although this is a safe procedure, it 
is associated with high morbidity due to incision pain and 
abdominal asymmetry.1 Sub-costal abdominal incision 
may produce less pain, because it causes less damage 
to the muscles and nerves of the abdominal wall and 
can potentially prevent abdominal wall weakness. The 
laparoscopic approach offers less postoperative pain and a 
more rapid return to daily activities. Although effective, the 
learning curve for the laparoscopic approach is steep and 
requires a trained team along with proper equipment.
In this study, a prospective analysis of the flank 
incision (FI), extra-peritoneal sub-costal incision (SC), and 
transperitoneal video-laparoscopic (VL) methods for donor 
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nephrectomy was performed to evaluate the outcomes of 
both donors and recipients. 
METHODS AND MATERIALS
From May 2001 to January 2004, 109 live renal 
transplants were evaluated. Donors and recipients were 
properly oriented before signing the informed consent forms. 
Two patients refused to enroll, and a total of 107 pairs of 
donors and recipients were studied in three groups: 38 VL, 
32 SC, and 37 FI. The criteria for the surgical approach 
were as follows. The VL approach was used in all left 
nephrectomies because of the larger extension of the left 
renal vein. For the right kidney, either the FI or SC approach 
was performed, allowing for use of the entire extension of 
the right vein with the aid of a vascular clamp on the inferior 
vena cava.
A single surgical team performed all open nephrectomies, 
while a team experienced with the minimally invasive 
approach executed the laparoscopic procedures. FI 
nephrectomies were performed with the patient in lateral 
decubitus with partial resection of the 12th rib. In the SC 
approach, the patient was positioned in a 30o oblique supine 
position and the incision made from the tip of the 12th rib to 
the rectus abdominis muscle. In the laparoscopic approach, 
the patient was also positioned in a 30-45o lateral decubitus 
using a maximum intracavitary pressure of 15 mmHg. The 
renal vessels were controlled with a Hem-O-Lok ® (Weck 
Closure Systems, Research Triangle Park, NC, USA) 
device. The kidney was extracted in an adequate retrieval 
bag through a transverse supra-pubic incision. Warm 
ischemia time was measured from renal arterial occlusion 
to immersion of the organ in the cold perfusion solution. All 
donors underwent the same follow-up protocol regardless of 
surgical approach. 
In order to evaluate the postoperative pain and analgesic 
intake, donors that did not undergo a pre-established form 
of anesthesia (epidural block associated with general 
anesthesia) as well as those who underwent surgical re-
exploration were excluded from this analysis. The patients 
rated their pain levels using a visual numeric scale. 
Postoperative analgesia consisted of metamizole sodium, 
which was administered either intravenously (1 g) or orally 
(0.75 g) upon the patient’s request. When metamizole 
sodium was insufficient, meperidine (20 mg) was used and 
a detailed record of administered dosages was maintained. 
After discharge, oral metamizole sodium was prescribed 
at the same dosage given during the hospital stay. Surgical 
re-intervention, blood transfusion, and abdominal wall 
infection were analyzed on the 90th day after surgery. Late 
postoperative complications were categorized as incisional 
problems, chronic pain, hypoesthesia, and abdominal wall 
asymmetries.
In the recipients, data regarding the terminal chronic 
renal insufficiency etiology, time of dialysis, level of 
immunological match between donor and recipient, 
and length of hospital stay were collected. The 
immunosuppression protocol was based on administration of 
cyclosporine, prednisone, and azathioprine or mycophenolate 
mofetil. Recipient surgical complications were analyzed 
in first- and second-time transplant recipients due to the 
fact that the iliac fossa was not previously manipulated. 
Regardless of condition, all recipients were considered for 
determination of the post-transplant graft and patient survival 
rates.
Serum creatinine was measured on the 1st, 3rd, 5th, 10th, 
30th, and 90th postoperative days, and when possible it was 
also measured one and two years after the transplant. For 
the analysis of creatinine levels, patients who underwent 
postoperative dialysis were not included in the measurements 
for the following ten days. Postoperative complications 
were categorized as vascular and ureteral abnormalities, 
lymphocele, hematoma, and need for another surgical 
intervention.
Univariate analysis was performed using the Student’s 
t-test for continuous parametric data, Wilcoxon rank sum 
test for continuous non-parametric data, Pearson’s Chi-
square test for categorical data, or Fisher exact test where 
appropriate. Within group comparisons were compared using 
paired t-tests. Kaplan-Meier survival curves were generated 
for analysis of recipient survival.
RESULTS
Demographics, surgical time, and warm ischemia time 
are reported in Table 1. All laparoscopic procedures were 
completed without open conversion. The mean warm 
ischemia time in the VL group was 2.7±1.3 min, which was 
significantly longer than that for the SC and FI groups (valor 
SC and valor FI, respectively). 
There was one pleural opening each in the SC (3.1%) 
and FI (2.7%) groups. Two patients, both from the VL group 
(1.9%), required re-operation. One patient underwent an 
exploratory laparotomy showing no abnormal findings on the 
second day after transplantation, whereas the second patient 
presented with hypotension and tachycardia associated with 
abdominal pain two hours after nephrectomy. In surgery, 
active bleeding was found at a lumbar vein that had been 
clipped. This patient was the only one in this pool of donors 
(0.9%) to receive a blood transfusion. The hospital stay 
for the FI group was significantly longer (p<0.001). There 
was a higher frequency of late incisional problems on the 
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90th postoperative day, where these were most frequently 
categorized as pain in the FI group and paresthesia and 
abdominal asymmetry in the FI and SC groups (Table 1). 
No deaths occurred in this group of donors. Data regarding 
the demographics of the 107 transplant recipients, duration 
of dialysis before the transplant, and post-transplant hospital 
stay length are shown in Tables 2 and 3.
Data regarding pain intensity and analgesic consumption 
were collected for 103 of the 107 donors. Four patients (all 
from the VL group) were excluded from this evaluation; two 
of the patients were excluded because they did not receive 
epidural anesthesia, and two were excluded because they 
underwent re-operation during the postoperative period. 
Data regarding the need for dialysis during the first week, 
delayed renal function, and immediate renal function are 
presented in Table 2. No statistically significant difference 
was noted among the three groups with regard to the 
immediate function of the transplanted organ (p=0.785). 
Table 1 - Donor demographics, pain scale, and analgesic use
VL (n=38) SC (n=32) FI (n=37) p-value
Age (yrs) 37.2 ± 7.0 40.2 ± 10.4 41.3 ± 12.4 p=0.528
Male (%) 21 (55.3%) 14 (43.8%) 8 (21.6%)*§ p=0.011
Related (%) 23 (60.5%) 24 (75%) 31 (83.8%) p=0.073
BMI 27.1 ± 3.8 26.6 ± 4.1 25.6 ± 4.0 p=0.302
Operative time (min) 168.7 ± 27.0†* 138.0 ± 12.2 150.9 ± 32.2 p<0.001
Warm ischemia (min) 3.3 ± 4.1†* 1.0 ± 0.4 1.0 ± 0.4 p<0.001
Hospital stay (days) 3.1 ± 0.9 3.3 ± 0.5 3.7 ± 0.6*§ p<0.001
Post-Operative Day VL SC FI p-value
1st 3.8 5.3 5.5* p=0.025
3rd 2.6 3.6 4.6* p=0.004
7th 1.7 1.8 2.7 p=0.059
Pain (90th) 3 (7.9%) 6 (18.8%) 14 (37.8%)*§ p=0.006
Paresthesia (90th) 1 (2.6%) 16 (50.0%)† 14 (37.8%)* p<0.001
Asymmetry (90th) 0 9 (28.1%)† 13 (35.1%)* p<0.001
Drug Consumption VL SC FI p-value
Meperidina Number of patients 1 (2.9%) 4 (12.5%) 8 (21.6%) p=0.060
Mean doses per group 0.03 ± 0.17 0.16 ± 0.45 0.32 ± 0.71 p=0.057
Mean amount per group (mg) 0.6 3.1 6.5 p=0.057
Metamizole Number of patients 34 32 37 -
Mean doses per group 6.7 ± 2.0 11.7 ± 3.8† 16.7 ± 3.4*§ p<0.001
Mean amount per group (g) 6.2 10.4† 14.5*§ p<0.001
* = (FI w VL). § = (FI w SC). † = (VL w SC)
Table 2 - Recipient demographics and graft function
VL (n=38) SC (n=32) FI (n=37) p-value
Age (yrs) 34.7 ± 15.8 32.7 ± 15.3 33.1 ± 15.0 p=0.879
Male (%) 17 (44.7%) 12 (37.5%) 17 (45.9%) p=0.751
Pre-transplant dialysis time (months) 29.6 ± 24.3 23.3 ± 23.0 29.8 ± 25.5 p=0.568
Hospital stay (days) 15.1 ± 12.7 13.5 ± 11.5 12.9 ± 8.4 p=0.881
Graft function VL (n=29) SC (n=29) FI (n=29) TOTAL (n=87)
Dialysis on first week (%) 3 (10.3%) 2 (6.9%) 4 (13.8%) 9 (10.3%)
Serum Cr > 3.0, 5th PO (%) 2 (6.9%) 2 (6.9%) 2 (6.9%) 6 (6.9%)
Immediate function (%) 24 (82.8%) 25 (86.2%) 23 (79.3%) 72 (82.8%)
Total, Delayed function (%) 5 (17.2%) 4 (13.8%) 6 (20.7%) 15 (17.2%)
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The mean creatinine levels of the 87 evaluated recipients 
are shown in Figure 1. Nine patients were excluded from 
this dataset due to the need for dialysis during the first week 
after transplantation. There was no statistically significant 
difference in the creatinine levels at any time during the 
postoperative period, frequency of vascular (p=0.834) or 
ureteral complications (p=1.0), or total complication rate 
(p=0.570) between groups. Of the 107 transplant recipients, 
the 9 patient deaths (8.4%) were equally distributed among 
all three groups (p=0.516, Figure 2). Four patients died 
during their initial hospital stay, two secondary to sepsis, 
and two due to cardiovascular complications. The other five 
deaths occurred during the late postoperative period, four of 
which were due to cardiovascular complications.
DISCUSSION
In the last decade, approaches with lower morbidity have 
been proposed for living kidney donors. Approximately 
over a similar period VL approaches to renal surgery 
have been developed and tested in Brazil.2,3 During In this 
study, we compared three approaches with respect to their 
benefits for donors and graft function. Because the VL 
and SC approaches were new at our institution, the first 
15 nephrectomies for each procedure were not included in 
this study to eliminate effects due to the learning curve.4-7
Initially, we found no evidence indicating that the VL 
approach was safe for kidneys with multiple arteries; when 
we faced such a condition, the right kidney was harvested.8,9 
In recent years, however, arterial multiplicity is no longer 
considered an exclusion criterion for laparoscopic donor 
nephrectomy.10
Pain intensity on an analog scale differed in all three 
groups, and a significant decline was noted on various 
postoperative days. The FI group presented the highest pain 
intensity during the follow-up period. A statistically significant 
difference in the first three postoperative days was observed in 
comparison to the VL group. The SC group presented lower 
Table 3 - Incidence of recipient complications by surgical approach
Complication VL (n=38) SC (n=32) FI (n=34) TOTAL (n=104)
Arterial complication 1 1 2 4 (3.8%)
Thrombosis 1 1 1 3 (2.8%)
Anastomosis rupture 0 0 1 1 (0.9%)
Ureteral complication 3 2 2 7 (6,7%)
Stenosis 3 0 2 5 (4.8%)
Urinary fistula 0 2 0 2 (1.9%)
Obstructive acute abdomen 1 0 0 1 (1,0%)
Lymphocele 1 0 1 2 (1.9%)
Hematoma 1 0 0 1
Figure 1 - Mean serum creatinine levels during hospitalization and follow-up Figure 2 - Recipient overall survival according to type of nephrectomy
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pain intensity in comparison to the FI group, but higher pain 
intensity than the VL group; however, these differences were 
not statistically significant. The difference in postoperative 
pain had a direct relationship with the amount of consumed 
analgesic. In the FI group, a greater number of patients 
required metamizole and meperidine during the hospital stay 
or after discharge. The hospital stay was longer in the FI 
group, but no difference in length was observed between the 
VL and SC groups. Other studies in the literature have noted 
similar results, with longer convalescence and longer times 
away from daily activities.11
In all groups, some late complications were related to 
the operative wound. In the VL group, four donors (10.5%) 
presented pain or paresthesia around the supra-pubic scar 
(Pfannestiel incision) used for organ extraction. As expected, 
there was no complaint or abdominal asymmetry 90 days 
after nephrectomy in this group. Pain, paresthesia, and/or 
abdominal asymmetry were observed in 19 (59.4%) and 24 
(64.9%) donors from the SC and FI groups, respectively. 
These rates are higher than the average of 48% reported in 
the literature, 14. Such a high complaint and asymmetry 
rates are undesirable in a group of healthy kidney donor 
volunteers. 
In the recipient group, there was no relationship between 
the approach used to harvest the kidney and its function in 
the recipient. As reported in previously published studies, 
this correlation shows that the longest surgical and warm 
ischemia times remain within a safe and reasonable range 
without impairment post-transplant renal function.12,13
Our data showed a higher rate of delayed graft function 
than did previous studies. We believe that this higher rate 
is related to intra-operative hypo-hydration. With strict 
adherence to a new protocol for donor hydration, this 
incidence was reduced to 5%. The complication rate was 
similar among the three groups. This data is supported by 
existing literature, which describe complication rates of up to 
31% for the VL approach and 19% for open surgery.14,15
Finally, there was no difference in the graft or recipient 
survival rates that could be attributed to the effect of warm 
ischemia time or manipulation of the kidney pedicle. The 
causes of mortality were predominantly cardiovascular or 
septic complications.14,16
CONCLUSIONS
Donor nephrectomy performed with the laparoscopic 
and anterior sub-costal approaches is just as safe as 
that performed via the standard flank oblique incision. 
The former techniques offer advantages with regard to 
postoperative pain, hospital stay, and late morbidity from the 
incision. The lower morbidity in the laparoscopic and sub-
costal approaches did not compromise the harvesting of an 
adequate organ, since graft function, surgical complications, 
and survival rates were similar in all groups.
REFERENCES
1. Johnson EM, Remucal MJ, Gillingham KJ, Dahms RA, Najarian 
JS, Matas AJ. Complications and risks of living donor nephrectomy. 
Transplantation. 1997;64:1124-8.
2. Lucon AM, Coelho RF, Chambô JL, Mitre AI, Praxedes JN, Srougi M. 
Hand-assisted laparoscopic right nephrectomy and autotransplantation 
for treatment of renovascular hypertension. Clinics. 2007;62:367-70.
3. Colombo JR Jr, Haber GP, Aron M, Cocuzza M, Colombo R, Kaouk 
J, Gill IS. Oncological outcomes of laparoscopic radical nephrectomy 
for renal cancer. Clinics. 2007;62:251-6.
4. Mitre AI, Dénes FT, Piovesan AC, Simões FA, Castilho LN, Arap S. 
Laparoscopic nephrectomy in live donor. Int Braz J Urol. 2004;30:22-
8.
5. Buzdon MM, Cho E, Jacobs SC, Jarrell B, Flowers JL. Warm ischemia 
time does not correlate with recipient graft function in laparoscopic 
donor nephrectomy. Surg Endosc. 2003;17:746-9.
6. Leventhal JR, Deeik RK, Joehl RJ, Rege RV, Herman CH, Fryer JP, et 
al. Laparoscopic live donor nephrectomy – is it safe? Transplantation. 
2000;70:602-6.
7. Rawlins MC, Hefty TL, Brown SL, Biehl TR. Learning laparoscopic 
donor nephrectomy safely: a report on 100 cases. Arch Surg. 
2002;137:531-5.
8. Kuo PC, Cho ES, Flowers JL, Jacobs S, Bartlett ST, Johnson LB. 
Laparoscopic living donor nephrectomy and multiple renal arteries. 
Am J Surg. 1998;176:559-63.
9. Kuo PC, Bartlett ST, Schweitzer EJ, Johnson LB, Lim JW, Dafoe DC. A 
technique for management of multiple renal arteries after laparoscopic 
donor nephrectomy. Transplantation. 1997;64:779-80.
10. Johnston T, Reddy K, Mastreangelo M, Lucas B, Ranjan D. Multiple 
renal arteries do not pose an impediment to the routine use of 
laparoscopic donor nephrectomy. Clin Transplant. 2001;15:62-5.
28
CLINICS 2009;64(1):23-8Comparative and prospective analysis of three different approaches for live-donor nephrectomy
Mitre AI et al.
11. Ratner LE, Montgomery RA, Kavoussi LR. Laparoscopic live donor 
nephrectomy: the four-year Johns Hopkins University experience. 
Nephrol Dial Transplant. 1999;14:2090-3.
12. London E, Rudich S, McVicar J, Wolfe B, Perez R. Equivalent 
renal allograft function with laparoscopic versus open live donor 
nephrectomies. Transplant Proc. 1999; 31:258-60.
13. Abreu SC, Goldfarb DA, Derweesh I, Thornton J, Urbain JL, Mascha 
E, et al. Factors related to delayed graft function after laparoscopic live 
donor nephrectomy. J Urol. 2004; 171:52-7.
14. Tooher RL, Rao MM, Scott DF, Wall DR, Francis DMA, Bridgewater 
FHG, et al. A systematic review of laparoscopic live-donor nephrectomy. 
Transplantation. 2004;78: 404-1.
15. Ratner LE, Montgomery RA, Maley WR, Cohen C, Burdick J, Chavin 
KD, et al. Laparoscopic live donor nephrectomy: the recipient. 
Transplantation. 2000;69:2319-23.
16. Merlin TL, Scott DF, Rao MM, Wall DR, Francis DMA, Bridgewater 
FHG, et al. The safety and efficacy of laparoscopic live donor 
nephrectomy: a systematic review. Transplantation. 2000;70:1659-66.
